In pancreatic cancer, HNF1A was shown to transcriptionally activate 53BP1 expression, with its expression negatively correlated with oxaliplatin chemoresistance in pancreatic ductal carcinoma (PDAC) tissues and cell lines. This evidence concerns the gene HNF1A and familial pancreatic carcinoma.